Article 15 of the Cosmetics Regulation and status of CMR substances, European catalogue of nanomaterials, future of ‘free from’ and ‘hypoallergenic’ claims… the participants of the Congress held by the Cosmetic Valley in Chartres on November 16-17, 2016, were mainly concerned about these issues – among others. Emma Trogen, of Cosmetics Europe, tackled them from a practical standpoint, before a question/answer session was organized with a European Commission representative.
After a screening of European regulatory affairs by Carlo Pettinelli, Director of the Consumer, Environmental, and Health Technology Department of the DG GROW (see our report on his presentation ), Emma Trogen, Director of Legal Affairs at Cosmetics Europe, presented the industry’s point of view on the same topics.
‘The past year was quite eventful as regards regulatory affairs,’ she started, ‘all federations representing the industry can confirm that. Certain issues on which we worked gave satisfactory results, and we gained some more legal certainty. But other issues remain unsolved…’
Article 15 of the Cosmetics Regulation and CMRs
Before dealing with this issue, Emma Trogen started with a reminder: in 2003, the former Cosmetics Directive had introduced an automatic ban on the use of substances classified as CMRs (Carcinogenic, Mutagenic, Reprotoxic substances) by means of the legislation on chemicals, but exemptions were granted for certain substances on the basis of a risk assessment.
In 2009, with the publication of Cosmetics Regulation 1223/2009, the Commission had interpreted Article 15 by changing how the automatic ban and exemptions would be managed.
As a result, the new procedure was related to the classification made under the CLP Regulation: in practice, deadline and regulatory …
